Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pinnacle Spine Group is a private U.S. medical device company focused on spinal fusion implants, graft delivery systems, and related surgical instrumentation. The company develops and markets its patented InFill Interbody Fusion Systems, which are designed to improve bone graft placement and graft-to-endplate contact during lumbar, cervical, TLIF, lateral, and ALIF fusion procedures. Its products are aimed at addressing the "biologic void" encountered in interbody fusion and are intended to improve surgical workflow and fusion outcomes. Pinnacle Spine Group appears to operate as a commercial-stage spine device business rather than a drug-development biotech company, with emphasis on implant design, surgeon usability, and spinal surgery instrumentation. The company is privately held and has been associated with backing from Sowell & Co.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Pinnacle Spine Group.